Share it:
DistilNFO Healthcare M & A
Healthcare M & A Advisory

Weekly Top Stories

Thur, 28 Jun 2018
1. Big Pharma makes strongest start to M&A for a decade
2. Mergers, acquisitions playing role in achieving scale, marketplace competition
3. 9 recent healthcare partnerships and transactions
4. Envision US$9.9bn leveraged buyout by KKR adds to private equity deal bonanza
5. Zoetis shareholders applaud $765M Pharmaq buy and strong earnings
6. How precision medicine, AI and the IoT are transforming healthcare M&A
7. LabCorp purchases retail division of Florida lab
8. Medidata acquires SHYFT analytics for $195M, adds analytics to life sciences suite
9. Esco Group to acquire AT Medical UAB, an Esco Ventures Portfolio Company
10. Bayer wins EU approval for $62.5 billion Monsanto buy
About Ed Francis
DistilNFO's Executive Editor & Senior Industry Strategist.
Ed is the National Life Sciences Practice lead for West Monroe Partners & has more than 20 years of management consulting experience guiding some of the industry’s most prominent organizations.
Subscribe to the Newsletter Here
Healthcare companies have announced almost $30bn of acquisitions since the beginning of the year in the sector’s strongest start for dealmaking in more than a decade, as Big Pharma scrambles to replace ageing blockbusters by paying top ...
Share: email linkedin twitter facebook
Mergers and acquisitions in healthcare have been accumulating at a mighty clip over the past several years, and a big part of the reason is scale. Consolidation helps healthcare organizations increase the scale of their business and retain ...
Share: email linkedin twitter facebook
The following healthcare mergers, acquisitions, partnerships and general transactions took place or were announced during the week of June 11. 1. 9 private equity firms gobbling up healthcare businesses Fifty-two percent of executives are ...
Share: email linkedin twitter facebook
Private equity firm KKR & Co’s US$9.9bn leveraged buyout of physician service provider Envision Healthcare has helped boost private equity deal volumes to levels not seen since before the credit crisis. Global private equity-backed ...
Share: email linkedin twitter facebook
Shares of Zoetis were up more than 5% by midday Tuesday to $46.45, after the company topped an acquisition announcement by posting better-than-expected earnings. On Monday night, Zoetis said it would purchase Norway-based Pharmaq, a maker ..
Share: email linkedin twitter facebook
Aspire Ventures, the private equity and venture capital group of Aspire Universal, recently partnered with the Penn Medicine Lancaster General Health network of hospitals to launch a $300 million fund to invest in personalized medical ...
Share: email linkedin twitter facebook
Laboratory Corporation of American Holdings is continuing its streak of acquisitions with a new deal to purchase a retail division of a laboratory in Florida. LabCorp, headquartered in Burlington, has purchased a portion of Vista Clinical ...
Share: email linkedin twitter facebook
Medidata said it will acquire SHYFT for $195 million in a deal designed to expand its reach in life sciences and clinical analytics. In a statement, the company said it already owned a 6 percent stake in SHYFT. Medidata combines CRM ...
Share: email linkedin twitter facebook
Esco Group announced today that it has reached an agreement to acquire the remaining shares in AT Medical UAB, an Esco Ventures portfolio company. AT Medical UAB is the developer of innovative IVF medical devices whose products are ...
Share: email linkedin twitter facebook
German conglomerate Bayer won EU antitrust approval on Wednesday for its $62.5 billion buy of U.S. peer Monsanto, the latest in a trio of mega mergers that will reshape the agrochemicals industry. The tie-up is set to create a company with ...
Share: email linkedin twitter facebook

Advertise with us

We Reach Quarter Million Decision Makers in:
Healthcare | IT | Retail | Industrial
Advertise with us and reach the right audience.

Contact Us

5760 Legacy Dr,
ste B3-405,
Plano TX 75024
+1 469-270-3311
advertise@distilnfo.com
Copyright 2018. All Rights Reserved. DistilNFO.
View in browser | Unsubscribe